FDA Probes Off-Label Uses Of Drug-Coated Stents

Law360, New York (March 12, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration reportedly met with a number of bile-duct stent manufacturers on Monday over alleged off-label uses of their products.

Meeting attendees were expected to include Boston Scientific Corp., Johnson & Johnson, Abbott Laboratories, ev3 Inc., C.R. Bard Inc. and Alveolus Inc., according to the Wall Street Journal.

A bile-duct, or biliary, stent is a plastic or metal device that props open the tubes that carry digestive fluids to the intestines. However, many doctors have also been using these stents to prop...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.